Trias Joaquim 4
4 · Anthera Pharmaceuticals Inc · Filed Sep 23, 2010
Insider Transaction Report
Form 4
Trias Joaquim
SR VP, Preclinical Development
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2010-09-21−4,380→ 0 totalExercise: $1.51From: 2009-04-15Exp: 2019-04-15→ Common Stock (4,380 underlying) - Exercise/Conversion
Common Stock
2010-09-21$1.51/sh+4,380$6,614→ 198,546 total